BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2807622
Number of visits today
67
Number of downloads
2059309
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Liang J, Zhang H, Huang Y, Fan L, Li F, Li M, Yan Y, Zhang J, Li Z, Yang X. A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy. Cancer Manag Res 2021;13:6977-87. [PMID: 34522140 DOI: 10.2147/CMAR.S330637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Mao L, Su S, Li J, Yu S, Gong Y, Chen C, Hu Z, Huang X. Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma. J Immunother 2023;46:89-95. [PMID: 36883998 DOI: 10.1097/CJI.0000000000000460] [Reference Citation Analysis]
2 Chen J, Xu Z, Hu C, Zhang S, Zi M, Yuan L, Cheng X. Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1132319] [Reference Citation Analysis]
3 Tian J, Bai T, Zhang Z, Zhai X, Wang K, Gao X, Yan B. Progress and prospects for use of cellular immunotherapy in pancreatic cancer. J Cancer Res Ther 2022;18:1867-75. [PMID: 36647944 DOI: 10.4103/jcrt.jcrt_976_21] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345